Valuation
- Market cap
- 4,809,000
- Revenue TTM
- $4,220,000
- Net income TTM
- $-12,430,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -294.55%
- Debt to equity
- 0.00
Trading
- Volume
- 7,546
- Avg volume
- 177,796
- Day's range
- $1.40 – $1.46
- Shares out
- 3,317,000
- Stochastic %K
- 20%
- Beta
- 4.31
- Analysts
- Sell
- Price target
- $12.00
Company profile
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known...
Show more
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 646 828 8258
- Website
- https://ibs.inc
- Address
- 135 West, 41st Street, 5th Floor, New York, United States
Latest news
No headlines yet.
